World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12605000554662
Date of registration: 29/09/2005
Prospective Registration: Yes
Primary sponsor: ORYGEN Research Centre
Public title: Vocational rehabilitation in first episode psychosis
Scientific title: The effect of vocational rehabilitation on employment and health outcomes in first episode psychosis: A randomised controlled pilot study
Date of first enrolment: 03/10/2005
Target sample size: 40
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12605000554662.aspx
Study type:  Interventional
Study design:  Purpose: Educational / counselling / training; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Phase 2 / Phase 3
Countries of recruitment
Australia
Contacts
Name: Dr Eoin Killackey   
Address:  University of Melbourne 35 Poplar Road Parkville VIC 3052 Australia
Telephone: +61 3 93422900
Email: eoin@unimelb.edu.au
Affiliation: 
Name: Dr Eoin Killackey   
Address:  University of Melbourne 35 Poplar Road Parkville VIC 3052 Australia
Telephone: +61 3 93422900
Email: eoin@unimelb.edu.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Stated desire to seek employment.
Exclusion criteria: Intellectual disability.

Age minimum: 15 Years
Age maximum: 25 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Mental Health - Psychosis and personality disorders
First-episode psychosis;
First-episode psychosis
Intervention(s)
6 month intervention with Youth Employment Specialist.
Primary Outcome(s)
Vocational status.[Measured at baseline and at the end of the 6 month intervention in the intervention group and at 6 months post baseline assessment in the control group.]
Secondary Outcome(s)
Quality of life[Measured at baseline and at the end of the 6 month intervention in the intervention group and at 6 months post baseline assessment in the control group.]
Symptom severity[Measured at baseline and at the end of the 6 month intervention in the intervention group and at 6 months post baseline assessment in the control group.]
Secondary ID(s)
Nil
Source(s) of Monetary Support
BMS
NHMRC - Program Grant
Secondary Sponsor(s)
The UNiversity of Melbourne
Ethics review
Status: Approved
Approval date:
Contact:
Melbourne Health Mental Health Research and Ethics Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history